Bernd Montag - Siemens Healthineers CEO, Member of the Managing Board
| SEMHF Stock | USD 53.36 0.69 1.28% |
CEO
Dr. Bernd Montag, Ph.D., was Chief Executive Officer, Member of the Managing Board of Siemens Healthineers AG since February 2015. He joined Siemens in 1995, after completion of his studies in Physics at the FriedrichAlexanderUniversity, ErlangenNuremberg, and earning a Ph.D. in theoretical multiparticle physics. He held positions in corporate quality management and sales in the hearing aid division before moving to imaging systems in 1999, where he served as a product manager for computed tomography and as the head of marketing for magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging Therapy Division, which combined the overall business of diagnostic imaging and imageguided therapies. since 2015.
| Tenure | 9 years |
| Phone | 49 9131 84 3385 |
| Web | https://www.siemens-healthineers.com |
Siemens Healthineers Management Efficiency
The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1129 %, meaning that it generated $0.1129 on every $100 dollars invested by stockholders. Siemens Healthineers' management efficiency ratios could be used to measure how well Siemens Healthineers manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | CEO Age | ||
| Joseph Dziedzic | Integer Holdings Corp | 56 | |
| AndreMichel Ballester | LivaNova PLC | 47 | |
| Mark Throdahl | Orthopediatrics Corp | 73 | |
| Vladimir Makatsaria | LivaNova PLC | 51 | |
| Gary Crosby | Paragon 28 | 61 | |
| Joseph Woody | Avanos Medical | 58 | |
| Karen Zaderej | Axogen Inc | 62 | |
| Kevin Thornal | Nevro Corp | 50 | |
| Massimo Calafiore | Orthofix Medical | N/A | |
| Thomas Hook | Integer Holdings Corp | 51 | |
| Albert DaCosta | Paragon 28 | 50 | |
| Charles Sherwood | Anika Therapeutics | 69 | |
| Damien McDonald | LivaNova PLC | 59 | |
| Bradley Mason | Orthofix Medical | 63 | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 |
Siemens Healthineers Leadership Team
Elected by the shareholders, the Siemens Healthineers' board of directors comprises two types of representatives: Siemens Healthineers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Siemens. The board's role is to monitor Siemens Healthineers' management team and ensure that shareholders' interests are well served. Siemens Healthineers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Siemens Healthineers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marion Helmes, Member of the Supervisory Board | ||
| Christian Klaussner, Ex Fin | ||
| Andreas Hoffmann, Member of the Supervisory Board | ||
| Carsten Bertram, Head Therapies | ||
| Bernhard Montag, President of the Management Board, CEO | ||
| Norbert Gaus, Vice Chairman of the Supervisory Board | ||
| Darleen Caron, Labor Officer | ||
| Nathalie Siemens, Member of the Supervisory Board | ||
| KarlHeinz Streibich, Member of the Supervisory Board | ||
| Marc Koebernick, Head Relations | ||
| Ralf Thomas, Member of the Supervisory Board | ||
| Andre Hartung, Head Imaging | ||
| Philipp Roesler, Member of the Supervisory Board | ||
| Gregory Sorensen, Member of the Supervisory Board | ||
| Michael Sen, Chairman of the Supervisory Board | ||
| Christopher Toth, Head Varian | ||
| Michael Reitermann, President of the Diagnostics Segment, Member of the Managing Board | ||
| Florian Flossmann, Head of Investor Relations | ||
| Bernd Montag, CEO, Member of the Managing Board | ||
| Michel DVM, Pres Therapies | ||
| Jochen Schmitz, CFO, Member of the Managing Board | ||
| Elisabeth Staudinger, Member Board |
Siemens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Siemens Healthineers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 59.39 B | |||
| Shares Outstanding | 1.12 B | |||
| Shares Owned By Insiders | 75.30 % | |||
| Shares Owned By Institutions | 11.85 % | |||
| Price To Earning | 29.13 X | |||
| Price To Book | 3.20 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Siemens Healthineers in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Siemens Healthineers' short interest history, or implied volatility extrapolated from Siemens Healthineers options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Siemens Healthineers AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Siemens Healthineers information on this page should be used as a complementary analysis to other Siemens Healthineers' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Siemens Pink Sheet analysis
When running Siemens Healthineers' price analysis, check to measure Siemens Healthineers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Siemens Healthineers is operating at the current time. Most of Siemens Healthineers' value examination focuses on studying past and present price action to predict the probability of Siemens Healthineers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Siemens Healthineers' price. Additionally, you may evaluate how the addition of Siemens Healthineers to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |